Is a complete NSE/AUROPHARMA research report available?

No complete published report is available for nse/AUROPHARMA (NSE/AUROPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/AUROPHARMA stock profile: metrics, valuation and analysis

Market cap	966.5B
Revenue (ttm)	349.4B
Net income (ttm)	37.1B
EPS (ttm)	₹64.0
Shares out	575.4M
P/E (trailing)	26.3x
P/E (forward)	20.5x
Dividend	₹8.00 (0.49%)
Volume	494,131
Beta	0.03

All NSE/AUROPHARMA indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

INR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	29,209
Employees Change	1,502%
Employees Change Percent	5.42
Enterprise value	INR 941.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.37
Industry PE Fwd	33.73
Isin	INE406A01037
Last refreshed	2026-09-12
Market cap	INR 966.5B
Price	INR 1,676
Price currency	INR
Rev Per Employee	11,960,453.97x
Sector	Healthcare
Sector PE	47.89
Sector PE Fwd	38.25
Sic	2834
Symbol	nse/AUROPHARMA
Website	https://www.aurobindo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.84%
EV Earnings	25.35x
EV/EBIT	17.61x
EV/EBITDA	13.26x
EV/FCF	33.14x
EV/Sales	2.69x
FCF yield	2.94%
Forward P/E	20.52x
P/B ratio	2.55x
P/E ratio	26.25x
P/S ratio	2.77x
PE Ratio10 Y	16.78x
PE Ratio3 Y	21.25x
PE Ratio5 Y	18.49x
PEG ratio	1.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	15.31%
EBITDA Margin	20.1%
FCF margin	8.44%
Gross margin	58.85%
Gross Profit	INR 205.6B
Gross Profit Growth	9.18%
Gross Profit Growth Q	19.32%
Gross Profit Growth3 Y	14.88%
Gross Profit Growth5 Y	7.38%
Net Income	INR 37.1B
Net Income Growth	9.47%
Net Income Growth Q	25.2%
Net Income Growth Qo Q	12.08%
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Net Income Growth3 Y	23.36%
Net Income Growth5 Y	-6.95%
Pretax Margin	15.51%
Profit Margin	10.63%
Profit Per Employee	INR 1.3M
Profitable Quarters	INR 56
Profitable Years	14
Roa5y	5.88
Roe5y	10.23
ROIC	10.35
Roic5y	10.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.2%
Cagr15y	24.63%
Cagr1y	59.61%
Cagr20y	18.51%
Cagr3y	25.31%
Cagr5y	18.35%
Div CAGR10	7.18%
Div CAGR3	-23.69%
Div CAGR5	-1.21%
EPS Growth	9.73
EPS Growth Q	25.78
EPS Growth Qo Q	12.63
EPS Growth Quarters	4
EPS Growth Years	3
EPS Growth3 Y	23.76
EPS Growth5 Y	-6.78
FCF Growth	45.17%
FCF Growth5 Y	8.48%
OCF Growth	40.81%
OCF Growth10 Y	14.56%
OCF Growth3 Y	32.3%
OCF Growth5 Y	10.67%
Revenue Growth	9.09x
Revenue Growth Q	16.3x
Revenue Growth Qo Q	3.35x
Revenue Growth Quarters	15x
Revenue Growth Years	4x
Revenue Growth3 Y	11.11x
Revenue Growth5 Y	7.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 105.8B
Debt	INR 80.7B
Debt EBITDA	INR 1.14
Debt Equity	INR 0.21
Debt FCF	INR 2.84
Equity	INR 378.8B
Interest Coverage	15.01
Net Cash	INR 25.1B
Net Cash By Market Cap	INR 2.6
Net Debt EBITDA	INR -0.36
Net Debt Equity	INR -0.07
Net Debt FCF	INR -0.88
Tangible Book Value	INR 327.9B
Tangible Book Value Per Share	INR 565
WACC	4.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.25%
Dividend Growth Years	1%
Dividend per share	INR 8
Dividend Years	25
Dividend Yield	0.49%
Ex Div Date	2025-08-08
Last Dividend	INR 4

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	119.86%
1Y total return	59.55%
200-day SMA	1,383.1
3Y total return	96.8%
50-day SMA	1,609
50-day SMA vs 200-day SMA	50over200
5Y total return	132.2%
All Time High	1,717
All Time High Change	-2.4%
All Time High Date	2026-08-31
All Time Low	10.13
All Time Low Change	16,451.11%
All Time Low Date	2008-11-06
ATR	37.77
Beta	0.03
Beta1y	0.09
Beta2y	0.37
Ch YTD	41.66
High	1,681.4
High52	1,717
High52 Date	2026-08-31
High52ch	-2.4%
Low	1,655.5
Low52	1,061.3
Low52 Date	2025-09-11
Low52ch	59.91%
Ma50ch	4.15%
Price vs 200-day SMA	21.16%
RSI	57.04
RSI Monthly	70.98
RSI Weekly	71.31
Sharpe ratio	1.8x
Sharpe Ratio3y	0.85x
Sharpe Ratio5y	0.57x
Sortino ratio	3.18
Sortino Ratio3y	1.52
Sortino Ratio5y	1.06
Total Return	0.74%
Tr YTD	41.66
Tr15y	2,620.38%
Tr1m	1.69%
Tr1w	2.35%
Tr3m	15.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	273,510,689%
Net Borrowing	-6,926,600,000
Shares Insiders	15.36%
Shares Institutions	31.4%
Shares Out	575,377,895
Shares Qo Q	-0.47%
Shares Yo Y	-0.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	807,171.4x
Bv Per Share	652.4
CAPEX	INR -26.9B
Ch10y	108.9
Ch15y	2,400.3
Ch1m	1.69
Ch1w	2.35
Ch1y	59.55
Ch20y	2,504.6
Ch3m	15.29
Ch3y	95.2
Ch5y	125.9
Ch6m	30.32
Change	0.44%
Change From Open	0.55
Close	1,668.4
Days Gap	-0.1
Depreciation Amortization	16,729,325,000
Dollar Volume	828,064,729.8
Earnings Date	2026-11-14
EBIT	INR 53.5B
EBITDA	INR 70.2B
EPS	INR 63.99
F Score	4
FCF	INR 28.4B
FCF EV Yield	3.02x
FCF Per Share	INR 49.37
Financing CF	-12,691,500,000
Fiscal Year End	March
Founded	1,986
Graham Number	969.18423
Graham Upside	-42.17
Income Tax	INR 17.1B
Investing CF	-34,586,100,000
Is Primary Listing	1
Last Earnings Date	2026-08-05
Last Report Date	2026-06-30
Last Split Date	2015-07-20
Last Split Type	Forward
Lynch Fair Value	INR 320
Lynch Upside	-80.91
Ma150	1,447
Ma150ch	15.81%
Ma20	1,649.8
Ma20ch	1.58%
Net CF	16,276,100,000
Next Earnings Date	2026-11-14
Open	1,666.7
P FCF Ratio	34.03
P OCF Ratio	17.49
Payment Date	2025-08-21
Position In Range	78.38
Price Date	2026-09-11
Price EBITDA	INR 13.77
Ptbv Ratio	2.95
Relative Volume	0.6x
Revenue	349,352,900,000x
Tax By Revenue	4.89x
Tax Rate	31.54%
Tr20y	2,887.06%
Tr6m	30.32%
Volume	494,131

NSE/AUROPHARMA (NSE/AUROPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/AUROPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/AUROPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/AUROPHARMA

Frequently asked questions